INTRODUCTION {#SEC1}
============

Nucleotide excision repair (NER) is a highly conserved 'cut-and-patch' DNA repair pathway that removes bulky and/or helix-distorting DNA lesions, such as UV induced cyclobutane pyrimidine dimers (CPDs) ([@B1],[@B2]). Transcription coupled repair (TCR) is a subpathway of NER that is dedicated to rapid removal of DNA lesions in the transcribed strand of actively transcribed genes. Global genomic repair (GGR) is the other subpathway of NER that removes lesions throughout the genome including the non-transcribed strand of actively transcribed genes. The two NER subpathways share most factors during the repair process, but differ in the initial damage recognition step.

TCR is triggered by an RNA polymerase, which is not a damage sensor *per se* but provides damage recognition specificity by a mechanism referred to as 'recognition by proxy' ([@B3]). In *Escherichia coli*, the transcription-repair coupling factor Mfd, a DNA-stimulated ATPase, binds to and displaces a lesion-stalled RNA polymerase by pushing it forward and concurrently recruits the NER machinery to the lesion site ([@B4]--[@B7]). Upon binding to ATP, Mfd also directly binds to DNA in a manner that the DNA wraps around the protein ([@B8]). The DNA binding activity may anchor Mfd for carrying out its transcription-repair coupling function ([@B9]). UvrD, a DNA helicase, has also been shown to facilitate TCR in *E. coli* ([@B10]). Unlike Mfd, UvrD forces the RNA polymerase to backtrack, thereby exposing DNA lesions for access of the repair machinery.

In eukaryotic cells, TCR occurs in RNA polymerase II (RNAP II) transcribed genes ([@B11]--[@B13]). A certain level of TCR has also been shown to occur in RNA polymerase I transcribed genes in the yeast *Saccharomyces cerevisiae* ([@B14]). It has been known for over two decades that Rad26, a DNA-dependent ATPase that is homologous to the human Cockayne syndrome B (CSB) protein, plays an important role in TCR in *S. cerevisiae* ([@B15]). It was initially assumed that Rad26 may facilitate TCR by serving as a transcription-repair coupling factor, like Mfd in *E. coli*. However, we and others have found that Rad26 is completely or partially dispensable for TCR in yeast cells lacking a number of TCR repressors, including Rpb4 ([@B16]), Spt4 ([@B17]), Spt5 ([@B18],[@B19]) and any subunit of the 5-subunit RNAP II associated factor complex (PAFc) ([@B20]). Rpb4 is a non-essential subunit of RNAP II and forms a subcomplex with Rpb7, another subunit of RNAP II ([@B21]--[@B23]). Spt4 and Spt5 are transcription elongation factors that form a complex ([@B24]). PAFc accompanies RNAP II throughout a gene and is involved in numerous transcription-related processes ([@B25]). It appears that the coordinated interactions of these TCR repressors with RNAP II hold the RNAP II complex in a closed conformation that is highly competent for transcription elongation but intrinsically repressive to TCR ([@B19]). The dispensability of Rad26 for TCR in the absence of a TCR repressor suggests that, instead of serving as a transcription-repair coupling factor, Rad26 may facilitate TCR indirectly by antagonizing the TCR repressors ([@B2],[@B12]).

Sen1 is a yeast ATPase-helicase that is the homolog of human senataxin, a protein implicated in ataxia ocular apraxia 2 (AOA2) ([@B26]) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS4) ([@B27]). Sen1 is essential for yeast cell viability and has been shown to be required for expression, maturation and termination of diverse classes of non-protein-coding RNAs ([@B28]--[@B31]). Sen1 has also been shown to directly bind to nascent protein-coding RNAs ([@B32]), affect RNAP II distribution ([@B33]), and provide a fail-safe transcriptional termination mechanism of protein-coding genes ([@B34]). Furthermore, Sen1 has been shown to protect the genome from transcription-associated recombination by resolving RNA:DNA hybrids (R-loops) naturally formed during transcription ([@B34],[@B35]).

A role for Sen1 in TCR was suggested by yeast-two-hybrid and immuno-pulldown assays, which showed that Sen1 interacts with Rad2 ([@B36]), a single-stranded DNA endonuclease that is essential for incision on the 3′ side of a lesion during NER (both GGR and TCR) ([@B2]). Rad2 interacts with and stabilizes TFIIH ([@B37]), a 10-subunit complex that is essential for both transcription initiation and NER ([@B38]). The Rad2-TFIIH interaction seems to be well conserved, as XPG, the human homolog of Rad2, also interacts with and stabilizes TFIIH in human cells ([@B39]). To date, whether Sen1 is implicated in TCR has not been directly tested. Here, we present evidence that Sen1 plays a more direct role than Rad26 in TCR.

MATERIALS AND METHODS {#SEC2}
=====================

Yeast plasmids and strains {#SEC2-1}
--------------------------

Plasmid vectors used in this study are pRS415 and pRS416, which bear *LEU2* and *URA3* as selection markers, respectively ([@B40]). *SEN1* gene fragments containing the native promoter and 3′ terminator and encoding the wild type, truncated or point mutant Sen1 proteins (Figure [1B](#F1){ref-type="fig"}) were amplified by PCR and inserted between the SacI and XhoI sites of the vectors. Plasmid pKS212, which bears a 1 kb EcoRI-XhoI fragment of the *RPB2* gene on the Bluescript pKS^+^ vector ([@B41]), was used for generating strand-specific RNA probes for the *RPB2* gene.

![Sen1 domains. (**A**) Schematic of Sen1 protein. Numbers indicate amino acid residue positions. The regions that interact with Rad2, Rnt1 and Rpb1, and with Nab3 are indicated by the bars below the schematic. (**B**) Sen1 proteins with truncations and point mutations used for analyses of UV induced DNA lesions. Yeast-two-hybrid interactions of some of the point mutations with Rad2, Rnt1 and Rpb1 are shown on the right. Based on ([@B36],[@B47],[@B48]).](gkw428fig1){#F1}

All yeast strains used in this study were derivatives of BJ5465 (*MATa ura3-52 trp1 leu2Δ1 his3Δ200 pep4::HIS3 prb1Δ1.6R can1*) ([@B42]). Deletions of *RAD2, RAD7, RAD26* and *SPT4* genes were done by using procedures as described previously ([@B16],[@B19]). To delete the genomic *SEN1* gene which is essential for cell viability, yeast cells were first transformed with a pRS416-based plasmid encoding *SEN1*. The genomic *SEN1* gene was then deleted using standard procedures. To create yeast cells specifically expressing the truncated and point mutant Sen1, the genomic *SEN1*-deleted cells were transformed with pRS415-based plasmids encoding the different Sen1 proteins. The transformants were cultured on plates containing uracil but not leucine to select for the *LEU2* plasmids and allow the loss of the *URA3* plasmid. The colonies were replica-plated onto plates containing 5-fluoroorotic acid, which is toxic to cells with a functional *URA3* gene ([@B43]), to select for cells that had lost the pRS416-based plasmid. The loss of the pRS416-based plasmid was confirmed by PCR.

Tests of UV sensitivity {#SEC2-2}
-----------------------

Yeast cells were grown at 30°C in synthetic dextrose (SD) medium to saturation, and 10-fold serial dilutions were made. The diluted yeast cells were spotted onto YPD (1% yeast extract, 2% peptone and 2% dextrose) plates, irradiated with appropriate doses of UV (254 nm) and incubated at 30°C in the dark. The plates were photographed after all the viable cells were able to form distinct colonies in a spot of well-diluted cells (3--5 days). The UV sensitivities were assessed by evaluating the numbers of distinct colonies (rather than by the overall cell growth intensities) in the spots.

Repair analysis of UV induced CPDs {#SEC2-3}
----------------------------------

Yeast cells were grown at 30°C in SD medium to late log phase (A~600~ ≈ 1.0), washed with ice-cold H~2~O, resuspended in 2% dextrose and irradiated with 120 J/m^2^ of UV. One‐tenth volume of a stock solution containing 10% yeast extract and 20% peptone was added to the irradiated cell suspension, and the cells were incubated in the dark at 30°C. At different times of the repair incubation, aliquots were removed and the genomic DNA was isolated using a hot SDS procedure as described previously ([@B44]).

To analyze repair of CPDs at specific sites, a nucleotide-resolution method was used ([@B45],[@B46]). One of the most obvious advantages of using the nucleotide-resolution method is that repair rates at different sites of a DNA fragment can be resolved on the same DNA sequencing gel, and thus a difference of repair among different sites or regions, where different NER mechanisms may be active, can be unambiguously identified. Briefly, the *RPB2* gene fragment was released from the genomic DNA by restriction digestion (DraI) and the DNA was incised at all CPD sites by using an excess amount of T4 endonuclease V (Epicentre). The *RPB2* fragments were fished out from other genomic fragments by using biotinylated oligonucleotides and streptavidin magnetic beads. The *RPB2* fragments were 3′ end labeled with \[α-^32^P\]dATP and Sequenase Version 2.0 (Affymetrix), resolved on sequencing gels and exposed to PhosphorImager screens. The intensities of gel bands corresponding to CPD sites were quantified by using the Quantity One software (Bio-Rad). Only GGR but not TCR is operative in the region that is over 40 nucleotides upstream of the transcription start site of the *RPB2* gene. For analyzing TCR in the transcribed strand of the *RPB2* gene in GGR-deficient *rad7Δ* cells, the band intensities in the region that is over 40 nucleotides upstream stream of the transcription start site were used to normalize signals of different gel lanes. The time required for repairing 50% of CPDs (*t*~1/2~) were calculated by linear or second-order polynomial regression of CPDs remaining at different time points of the repair incubation.

As GGR is operative at all sites along a gene, it is impossible to accurately normalize the signals among different gel lanes by using the signal intensities at certain CPD sites on a sequencing gel. We therefore also used a Southern blot assay to analyze GGR in the non-transcribed strand of the *RPB2* gene. Briefly, 0.2 μg of genomic DNA was digested with Acc65I and PvuI to release the 4.5 kb *RPB2* fragment. Half of each sample was mock-treated and the other half was treated with an excess amount of T4 endonuclease V to incise at CPDs. The DNA was electrophoresed in 0.8% alkaline agarose gels, blotted to positively charged Nylon membranes (Hybond-N^+^, GE Healthcare Life Sciences). The non-transcribed strand of the *RPB2* gene was hybridized with \[α-^32^P\] UTP labeled RNA probes. The probes were synthesized by cleaving plasmid pKS212 ([@B41]) with EcoRI and incubating the linearized plasmid with rNTPs, \[α-^32^P\] UTP and T3 RNA polymerase (New England Biolabs) under conditions recommended by the manufacturer. The probe-hybridized membranes were exposed to PhosphorImager screens and the bands were quantified by using the Quantity One software. The CPD content in the fragment was calculated by using the equation -- ln(RF~a~/RF~b~), where RF~a~ and RF~b~ represent the signal intensities of the intact restriction fragments of the T4 endonuclease V and mock-treated DNA, respectively.

RESULTS {#SEC3}
=======

The N-terminal non-essential region of Sen1 is important for TCR, whereas the C-terminal nonessential region plays a minor role in the repair process {#SEC3-1}
-----------------------------------------------------------------------------------------------------------------------------------------------------

Sen1 is essential for yeast cell viability. The minimal essential region of Sen1 corresponds to the ATPase-helicase domain and one of the two flanking nuclear localization sequences ([@B47]) (Figure [1A](#F1){ref-type="fig"}). To determine whether Sen1 plays a role in TCR, we analyzed repair of UV induced CPDs in the transcribed strand of the *RPB2* gene in *rad7Δ* and *rad7Δ rad26Δ* cells expressing Sen1 proteins with truncations or point mutations (Figure [2](#F2){ref-type="fig"}). Rad7 is essential for GGR, but completely dispensable for TCR ([@B2]). Therefore, the overall TCR and Rad26-independent TCR can be unambiguously analyzed in *rad7Δ* and *rad7Δ rad26Δ* cells, respectively. A nucleotide resolution method, which utilizes biotinylated oligonucleotides and streptavidin magnetic beads to facilitate fishing-out and strand-specific end-labeling of specific DNA fragments, was used for the analysis ([@B45],[@B46]). As expected, TCR was fast in the transcribed strand of the *RPB2* gene in *rad7Δ* (*SEN1^+^*) cells (Figures [2A](#F2){ref-type="fig"}, [3A](#F3){ref-type="fig"} and [4A](#F4){ref-type="fig"}). As only GGR but not TCR is operative in the region that is over 40 nucleotides upstream of the *RPB2* gene, no apparent repair can be seen in this upstream region in *rad7* cells (Figure [2A](#F2){ref-type="fig"}, marked with the open bar at the bottom-left; Figure [3A](#F3){ref-type="fig"}). Therefore, the band intensities in this upstream region can be used to unambiguously normalize the signals of different gel lanes. *rad7Δ rad26Δ* cells showed decreased TCR in the coding region of the *RPB2* gene, except for certain sites especially those in the short region (∼50 nucleotides) immediately downstream of the transcription start site (Figures [2E](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

![DNA sequencing gels showing repair of CPDs in the 1.1 kb DraI fragment of the transcribed strand of the *RPB2* gene in *rad7Δ* and *rad7Δ rad26Δ* cells expressing the wild type and different Sen1 mutants. Samples were from unirradiated (U) and UV irradiated cells at different times (h) of repair incubation. The top strong band corresponds to the full-length restriction fragment of the *RPB2* gene containing no DNA lesion. Bands below the top band correspond to CPD sites. Decrease of band intensities with time reflects repair. Approximate nucleotide positions relative to the transcription start site of the *RPB2* gene are indicated on the left of (**A**). Open bar at the bottom-left of (A) marks the upstream region of the *RPB2* gene where only GGR but not TCR is operative and thus is not repaired in *rad7Δ* cells. The band intensities in this upstream region can be used to normalize signals in different lanes of the gels. Bracket on the left of (**E**) indicates the region where robust Rad26-independent TCR occurs.](gkw428fig2){#F2}

![Time (h) required for repairing 50% (*t*~1/2~) of CPDs at individual sites of the transcribed strand of the *RPB2* gene in *rad7Δ* and *rad7Δ rad26Δ* cells expressing the wild type and different Sen1 mutants. The nucleotide numbers are relative to the transcription start site of the *RPB2* gene. The *t*~1/2~ values were calculated by linear or second-order polynomial regression of the CPDs remaining at different repair times.](gkw428fig3){#F3}

![Plots showing percent CPDs remaining in the coding region of the transcribed strand of the *RPB2* gene in (**A**) *rad7Δ*, (**B**) *rad7Δ rad26Δ*, (**C**) *rad7Δ Spt4Δ* and (**D**) *rad7Δ rad26Δ spt4Δ* cells expressing the wild type (red symbols) and different Sen1 mutants (black symbols). The means (± SD) of CPDs remaining at each indicated repair time in cells expressing the N-, and N- and C-terminal truncated Sen1 (sen1-NΔ/NΔ+CΔ, which include sen1-975-2231, sen1-1089-2231, sen1-1004-1907 and sen1-1089-1929) were plotted in blue. The TCR rates in the sen1-NΔ/NΔ+CΔ cells were significantly slower than those in wild type cells (*P* \< 0.01, Student\'s *t-*test).](gkw428fig4){#F4}

Truncation of the N- or N- and C-terminal non-essential regions of Sen1 significantly reduced TCR at essentially all sites in the *RPB2* gene, including those in the short region immediately downstream of the transcription start site (Figure [2](#F2){ref-type="fig"}, compare B and C with A, and F and G with E; Figure [3](#F3){ref-type="fig"}; Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}; Supplementary Figure S1). Indeed, TCR at most sites of the *RPB2* gene in *rad7Δ sen1-1004-1907, rad7Δ sen1-1089-1929* and *rad7Δ sen1-1089-2231* cells were even significantly slower than that in *rad7Δ rad26Δ* cells (Figure [2](#F2){ref-type="fig"}, compare B and C with E; Figure [3](#F3){ref-type="fig"}; Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}). Truncation of the entire C-terminal nonessential region of Sen1 caused a mild TCR deficiency (Figure [2](#F2){ref-type="fig"}, compare D with A, and H with E; Figure [3](#F3){ref-type="fig"}; Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}). These results indicate that the N-terminal non-essential region of Sen1 plays a more important role in TCR than the C-terminal non-essential region.

The N-terminal 565 residues of Sen1 have been shown by yeast-two-hybrid assays to be involved in interactions with Rad2, Rpb1 (the largest subunit of RNAP II) and Rnt1 (an RNA processing factor) ([@B48]). A number of point mutations in the N-terminal region of Sen1 were shown to abolish all or some of the interactions ([@B48]). We found that truncation of the N-terminal 565 residues caused a TCR deficiency (not shown) that is similar to that caused by truncation of the N-terminal 975 residues (Supplementary Figure S1, panels C and G). However, E58K, K128E, R197E and R302W mutations of Sen1, which were shown to abolish interaction with Rad2, Rnt1 and/or Rpb1 ([@B48]) (Figure [1B](#F1){ref-type="fig"}), caused no significant TCR deficiency (not shown).

Rpb9, a non-essential subunit of RNAP II, has been shown to be required for Rad26-independent TCR ([@B16]). To determine the functional interactions of Sen1 and Rpb9 during TCR, we attempted to create *rad7Δ rpb9Δ* and *rad7Δ rad26Δ rpb9Δ* cells expressing the N- or N- and C-terminal non-essential region truncated Sen1. However, these cells appear to be inviable. Therefore, Rpb9 and the N-terminal non-essential region of Sen1 may complement with each other for cell viability.

The ATPase-helicase activity of Sen1 plays a minor role in TCR {#SEC3-2}
--------------------------------------------------------------

The E1597 residue is located in the ATPase-helicase domain of Sen1 and forms an intra-domain salt bridge with R1641 ([@B47]). The E1597K mutation has been shown to abolish its ATPase-helicase activity and compromise transcription termination ([@B28],[@B33],[@B49],[@B50]). Interestingly, this mutation only caused a mild TCR deficiency (Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}; Supplementary Figure S1, compare D with A, and H with E), indicating that the helicase activity of Sen1 plays a minor role in TCR. In agreement with this notion, the G1747D mutation, which also abolishes its ATPase-helicase activity ([@B51]), also caused a mild TCR deficiency (similar to that caused by the E1597K mutation) (not shown).

To examine if the ATPase-helicase activity of Sen1 acts synergistically or additively with its N-terminal non-essential region in TCR, we attempted to create yeast cells expressing Sen1 with the N-terminal 975 residue truncation and the E1597K or G1747D mutation. However, Sen1 with both the truncation and point mutation appears to be lethal for the cell.

Deletion of *SPT4* cannot fully restore TCR in cells expressing the N- or N- and C-terminal truncated Sen1 {#SEC3-3}
----------------------------------------------------------------------------------------------------------

In agreement with previous reports showing that deletion of *SPT4* can fully restore TCR in cells lacking Rad26 ([@B17]), the TCR rate in *rad7Δ rad26Δ spt4Δ* cells was similar to that in *rad7Δ* cells (compare Figures [2A](#F2){ref-type="fig"}, [2E](#F2){ref-type="fig"} and [5E](#F5){ref-type="fig"}; Figure [4A](#F4){ref-type="fig"}, [B](#F4){ref-type="fig"} and [D](#F4){ref-type="fig"}). However, TCR rates in *rad7Δ rad26Δ spt4Δ* cells expressing the N- or N- and C-terminal truncated Sen1 were much slower than those in *rad7Δ rad26Δ spt4Δ* (*SEN1^+^*) (Figure [5](#F5){ref-type="fig"}, compare F and G with E; Supplementary Figure S2, compare E and F with D) and *rad7Δ* (*SEN1^+^*) (compare Figure [5F](#F5){ref-type="fig"} and [G](#F5){ref-type="fig"} with Figure [2A](#F2){ref-type="fig"}; Figure [4](#F4){ref-type="fig"}, compare A with D) cells, indicating that TCR cannot be fully restored by deleting Spt4 in cells expressing the truncated Sen1. Also, TCR rates in *rad7Δ spt4Δ* cells expressing the N- or N- and C-terminal truncated Sen1 were significantly slower than those in *rad7Δ spt4Δ* (*SEN1^+^*) (Figure [5](#F5){ref-type="fig"}, compare B and C with A; Supplementary Figure S2, compare B and C with A) and *rad7Δ* (*SEN1^+^*) (compare Figure [5B](#F5){ref-type="fig"} and [C](#F5){ref-type="fig"} with Figure [2A](#F2){ref-type="fig"}; Figure [4](#F4){ref-type="fig"}, compare A and C) cells, further indicating that deletion of *SPT4* cannot fully restore TCR in the Sen1 truncation mutant cells. These results suggest that Sen1 plays a more direct role than Rad26 in TCR, and is not completely dispensable for the repair even in the absence of the TCR repressor Spt4.

![DNA sequencing gels showing repair of CPDs in the transcribed strand of the *RPB2* gene in *rad7Δ spt4Δ* and *rad7Δ rad26Δ spt4Δ* cells expressing wild type and different Sen1 mutants. See Figure [2](#F2){ref-type="fig"} for more explanations of the labels.](gkw428fig5){#F5}

The N- and C-terminal truncations of Sen1 do not significantly affect GGR {#SEC3-4}
-------------------------------------------------------------------------

To determine if Sen1 also plays a role in GGR, we analyzed repair of CPDs at individual sites in the non-transcribed strand of the *RPB2* gene in cells expressing the N- and C-terminal non-essential region truncated Sen1. Cells with the truncated Sen1 showed essentially the same repair rate as those expressing the wild type Sen1 (Figure [6](#F6){ref-type="fig"}), indicating that the truncations do not significantly affect GGR.

![(**A**--**C**) DNA sequencing gels showing repair of CPDs in the 1.1 kb DraI fragment of the non-transcribed strand of the *RPB2* gene in cells expressing wild type Sen1 (WT), and sen1-1004-1907 and sen1-1089-1929 mutants. (**D**) Plot showing percent CPDs remaining in the non-transcribed strand of the *RPB2* gene in the wild type and mutant cells. Repair rates in cells expressing sen1-1089-1929 and sen1-1004-1907 mutants were not significantly different from those expressing the WT (Student\'s t*-*test). Error bars (SD) for the wild type and Sen1 mutants overlap and are not shown for clarity.](gkw428fig6){#F6}

As GGR is operative at all sites along a gene, it is impossible to accurately normalize the signals among different gel lanes by using the signal intensities at certain CPD sites on a sequencing gel. We therefore further analyzed GGR by measuring overall repair of CPDs in the 4.5 kb Acc65I-PvuI fragment of the non-transcribed strand of the *RPB2* gene by using Southern blot. Cells with the N- and C-terminal truncated Sen1 showed essentially the same repair rate as those expressing the wild type Sen1 (WT) (Figure [7](#F7){ref-type="fig"}), further indicating that the truncations do not significantly affect GGR.

![(**A**) Southern blot showing repair of CPDs in the 4.5 kb (Acc65I*-*PvuI) fragment of the non-transcribed strand of the *RPB2* gene in cells expressing WT, and sen1-1004-1907 and sen1-1089-1929 mutants. (**B**) Plot showing percent CPDs remaining in the non-transcribed strand of the *RPB2* gene in the wild type and mutant cells. The values shown are averages of two experiments (line bars indicate the range of the two experimental values).](gkw428fig7){#F7}

Epistatic interactions of *SEN1* with *RAD26, RAD7* and *RAD2* {#SEC3-5}
--------------------------------------------------------------

To determine if the role of Sen1 in DNA repair is limited to TCR, we analyzed epistatic interactions of *SEN1* with *RAD7, RAD26* and *RAD2*. In agreement with previous reports ([@B15],[@B16],[@B52]), deletion of *RAD26* did not significantly increase the UV sensitivity of otherwise wild type cells (Figure [8](#F8){ref-type="fig"}, compare *SEN1* samples in panels A and B), but moderately increased the UV sensitivities of *rad7Δ* cells (Figure [8](#F8){ref-type="fig"}, compare *SEN1* samples in panels D and E). The *sen1-1089-1929* mutant increased UV sensitivities of all the yeast strains tested (Figure [8](#F8){ref-type="fig"}), indicating that this mutant has deficiencies not only in TCR but also in a non-NER pathway that is implicated in repair and/or tolerance of UV induced DNA lesions. How the *sen1-1089-1929* mutant is implicated in the non-NER pathway was not pursued in this study. All the other N- or N- and C-terminal truncated Sen1 mutants did not increase the UV sensitivities of *rad26Δ, rad2Δ* or otherwise wild type cells (Figure [8A](#F8){ref-type="fig"}, [B](#F8){ref-type="fig"} and [C](#F8){ref-type="fig"}), but increased the UV sensitivities of *rad7Δ* and *rad7Δ rad26Δ* cells (Figure [8D](#F8){ref-type="fig"} and [E](#F8){ref-type="fig"}). This indicates that the deficiencies of the latter Sen1 truncation mutants in repairing UV lesions are limited to TCR. The *sen1-E1597K* (Figure [8E](#F8){ref-type="fig"} and data not shown) and *sen1-G1747D* (not shown) mutants did not significantly increase the UV sensitivities of all the yeast strains tested, indicating that the ATPase-helicase activity of Sen1 does not play a major role in NER (TCR or GGR) or other DNA repair pathways responsible for removal and/or tolerance of UV lesions.

![Effects of Sen1 truncation and point mutations on UV sensitivities of yeast cells with different NER subpathways operative. Panels show growth of 10-fold serially diluted yeast cells spotted on plates after different doses of UV irradiation. The plates were photographed after all the viable cells were able to form distinct colonies in a spot of well-diluted cells (3--5 days). The UV sensitivities were assessed by evaluating the numbers of distinct colonies (rather than by the overall cell growth intensities) in the spots.](gkw428fig8){#F8}

DISCUSSION {#SEC4}
==========

We showed here that Sen1 plays an important role in TCR. While deletion of *SPT4* in *rad26Δ* cells can fully restore TCR, the deletion can only partially restore TCR in cells expressing the N- or N- and C-terminal non-essential region truncated Sen1. Therefore, unlike Rad26, which appears to facilitate TCR solely by antagonizing TCR repressors, Sen1 may facilitate TCR not only by antagonizing TCR repressors but also through a more direct mechanism.

In view of the yeast-hybrid studies showing that Sen1 interacts with Rpb1, the largest subunit of RNAP II and Rad2, an essential NER factor ([@B36],[@B48]), it is tempting to propose that Sen1 may be a true transcription-repair coupling factor in yeast, like Mfd in *E. coli*. However, although deletion of the N-terminal 565 residues of Sen1 caused a TCR deficiency, point mutations in this region that were shown to abolish Sen1 interactions with Rpb1 and/or Rad2 did not seem to cause any TCR defect. One possibility is that the interactions are not important for TCR. Alternatively, unlike the yeast-two-hybrid situations, the point mutations may not abolish Sen1 interactions with Rpb1 and/or Rad2 under native conditions. Also, while the ATPase activity of Mfd is essential for its TCR activity in *E. coli* ([@B7]), the ATPase activity of Sen1 seems to play a minor role in the yeast TCR. Therefore, the functional mechanism of Sen1 in yeast TCR may not be identical to that of Mfd in *E. coli* TCR. Furthermore, the helicase activity of UvrD appears to be required for its TCR function in *E. coli* ([@B10]). Sen1 may also behave differently from UvrD in TCR.

The ATPase-helicase domain of Sen1 is essential for cell viability. Although the helicase activity of Sen1 plays a minor role in TCR, the importance of this domain for this repair pathway remains to be elucidated. In addition to its helicase activity, this domain may play a structural role in TCR. The residual TCR in *rad7Δ* and *rad7Δ rad26Δ cells* expressing the N- or N- and C-terminal truncated Sen1 might be accomplished by the ATPase-helicase domain. The partially restored TCR in *rad7Δ spt4Δ* and *rad7Δ rad26Δ spt4Δ* cells expressing the truncated Sen1 might also be due to the ATPase-helicase domain. If this is the case, all TCR subpathways, Rad26-dependent and independent, may be eventually dependent on Sen1. Identification and characterization of potential TCR-deficient mutations in the ATPase-helicase domain of Sen1 may be greatly informative for addressing the question.

It has been well-known that Sen1 is a subunit of the Nrd1-Nab3-Sen1 complex ([@B53]). Sen1 directly interacts with Nab3 but not with Nrd1 ([@B31],[@B36],[@B54],[@B55]). Yeast-two-hybrid assays have shown that the C-terminal nonessential region of Sen1 that interacts with Nab3 includes residues 1890--2092 ([@B55]) (Figure [1A](#F1){ref-type="fig"}). We found here that truncation of the whole C-terminal non-essential region (residues 1859--2231) of Sen1 caused a minor TCR deficiency. It is therefore likely that the interaction of Sen1 with Nab3 (and indirectly with Nrd1) may not play a major role in TCR.

In short, we identified Sen1 as a new TCR facilitator in yeast. How Sen1 functions in TCR remains to be elucidated. Also, if its homolog senataxin plays a similar role in TCR in human cells remains to be tested.
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